benazepril hydrochloride and hydrochlorothiazide
- Product NDC
- 64980-194
- 11-digit product format
- 649800194
- Labeler code
- 64980
- Product ID
- 64980-194_e7488c2e-9385-4ad1-b211-24adbbed407e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benazepril hydrochloride and hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc.
- Application
- NDA020033
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-03-20
- Marketing end
- 0000-00-00
- Substance
- BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-194-01 | 64980019401 | 100 TABLET in 1 BOTTLE (64980-194-01) | 100 tablet | 2014-03-20 | 0000-00-00 | No | No | Current |